ELISA Diagnostics Tests Market, By Test Type (Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA, and Sandwich ELISA), By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4159
|
Published Date
July 2025
|
Pages
269
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
ELISA Diagnostics Tests Market size was valued at US$ 1,690.32 Million in 2024, expanding at a CAGR of 5.93% from 2025 to 2032.
The global Enzyme-Linked Immunosorbent Assay (ELISA) market centers around a widely used diagnostic test designed to detect and quantify antibodies, antigens, proteins, and hormones in biological samples. ELISA is primarily used to determine whether a sample contains antibodies associated with specific infectious diseases or immune responses. The test works by adsorbing an antigen onto a solid surface (typically a microplate), followed by the introduction of an enzyme-linked antibody that binds to the target antigen. Upon adding a substrate specific to the enzyme, a detectable signal—usually a color change—is produced, indicating the presence and concentration of the target substance.
ELISA plays a crucial role in diagnosing viral infections such as HIV, syphilis, rotavirus, Zika virus, and varicella-zoster virus (which causes shingles and chickenpox). It is often used as a preliminary screening tool before more advanced confirmatory tests and is valued for its high sensitivity, specificity, and ease of use. Beyond infectious disease diagnostics, ELISA also finds broad applications in pharmaceutical quality control, including endotoxin detection, protein quantification, and vaccine development. As the demand for rapid, reliable diagnostics continues to grow—particularly in emerging healthcare markets—the ELISA market is poised for sustained expansion driven by technological advancements and increased adoption in both clinical and research settings.
ELISA Diagnostics Tests Market- Market Dynamics
Rising Disease Burden Fuels Demand for Early Diagnostic Solutions
The global increase in both infectious and chronic diseases is fueling the need for early and precise diagnostic tools, with ELISA (Enzyme-Linked Immunosorbent Assay) tests playing a critical role in this effort. Known for their high sensitivity and specificity, ELISA tests can detect specific proteins, antigens, and antibodies early in the disease progression, enabling timely intervention and improved patient outcomes. Major diagnostic companies such as Thermo Fisher Scientific and Bio-Rad Laboratories widely utilize ELISA kits for early detection of diseases like HIV, helping to reduce transmission and support effective treatment strategies. During the COVID-19 pandemic, Abbott developed ELISA-based antibody tests to identify previous infections, aiding public health initiatives and guiding vaccine distribution efforts.
Beyond infectious diseases, ELISA is also pivotal in oncology diagnostics. For example, Bio-Techne offers ELISA kits targeting cancer biomarkers such as PSA (Prostate-Specific Antigen) and CA-125, supporting early detection and ongoing treatment monitoring. These advancements underscore how the growing global disease burden is driving demand for sensitive, cost-effective, and reliable diagnostic solutions. Healthcare systems are increasingly prioritizing technologies like ELISA to enhance early diagnosis, improve patient care, and reduce overall healthcare costs.
For instance:
- In October 2021, Siemens Healthineers launched a new ELISA-based assay aimed at the early detection of autoimmune diseases, such as rheumatoid arthritis and lupus. This innovation addresses the rising global incidence of autoimmune disorders and empowers clinicians to diagnose and manage complex diseases earlier and more effectively.
ELISA Diagnostics Tests Market- Segmentation Analysis:
The global ELISA diagnostics tests market is segmented on the basis of test type, application, end user, and region.
The global ELISA (Enzyme-Linked Immunosorbent Assay) market is segmented by test type into competitive ELISA, indirect ELISA, multiple & portable ELISA, and sandwich ELISA, with the sandwich ELISA segment currently dominating the market. This dominance is attributed to its superior sensitivity and specificity, particularly in detecting low concentrations of biomarkers within complex biological samples such as blood or serum. The sandwich ELISA technique captures the target antigen between two antibodies—one for capture and the other for detection—greatly enhancing diagnostic accuracy. This method is widely utilized in clinical diagnostics for applications such as infectious disease detection, cancer biomarker identification, and hormone level measurement. Its ability to provide quantitative and reproducible results makes it a preferred choice among healthcare providers, diagnostic labs, and research institutions. According to the World Health Organization (WHO), early and accurate diagnostic testing plays a critical role in managing global health threats, including infectious diseases and cancer, which collectively account for more than 50% of the global disease burden—underscoring the significance of technologies like sandwich ELISA in global health diagnostics.
Based on end user, the ELISA market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and veterinary hospitals & diagnostic laboratories, with hospitals and diagnostic centers holding the largest market share. This is driven by their pivotal role in routine disease diagnosis, patient monitoring, and public health screening programs. The widespread use of ELISA tests in these clinical settings to detect infectious diseases, chronic illnesses, and various health markers makes them the primary consumers of ELISA kits and reagents. Hospitals and diagnostic centers rely on rapid, accurate, and high-throughput testing solutions to manage increasing patient loads and complex health concerns, which continues to fuel the demand for ELISA-based diagnostics. According to the OECD Health Statistics, over 75% of diagnostic decisions in hospitals are influenced by laboratory testing, emphasizing the critical role of reliable diagnostic tools such as ELISA in modern healthcare delivery systems.
ELISA Diagnostics Tests Market- Geographical Insights
North America Leads the Global ELISA Diagnostic Tests Market in 2024
North America holds the largest share in the global ELISA diagnostic tests market, largely due to its well-established healthcare infrastructure and the high volume of diagnostic testing conducted across the region. The market benefits from strong public and private sector investment in medical research, public health initiatives, and biotechnology development. Leading diagnostic companies such as Thermo Fisher Scientific, Abbott, and Bio-Rad Laboratories are based in the region, driving continuous innovation and availability of high-quality ELISA kits and automated instruments. ELISA tests are routinely used in hospitals and clinical laboratories throughout the United States and Canada to detect a wide range of infectious diseases, autoimmune conditions, and chronic illnesses. Additionally, high awareness around the importance of early disease detection, combined with favorable reimbursement policies, supports the widespread use of these diagnostic tools. According to the Centers for Disease Control and Prevention (CDC), laboratory services are involved in approximately 70% of clinical decision-making in the U.S., underlining the importance of technologies like ELISA in guiding diagnosis and treatment.
Asia-Pacific Expected to Record the Highest CAGR in the ELISA Diagnostic Tests Market in 2024
The Asia-Pacific region is witnessing the fastest growth in the ELISA diagnostic tests market, driven by a rising prevalence of infectious and lifestyle-related diseases. Countries such as China, India, and those in Southeast Asia are actively expanding their healthcare infrastructure and making significant investments in modern diagnostic technologies. Growing public and professional awareness of early diagnosis and disease prevention is contributing to higher adoption rates of ELISA-based testing methods. Furthermore, government-led health initiatives and nationwide screening programs are helping to improve diagnostic accuracy and reach, especially in underserved areas. The affordability of ELISA kits makes them especially attractive in cost-sensitive healthcare systems, further accelerating their uptake. According to the World Health Organization (WHO), Asia-Pacific bears a significant share of the global burden of infectious diseases, prompting many governments in the region to implement large-scale public health programs and laboratory capacity-building efforts, which continue to drive demand for reliable diagnostics like ELISA.
ELISA Diagnostics Tests Market- Competitive Landscape:
The ELISA diagnostic tests market is highly competitive, characterized by a blend of global giants and emerging regional players. Companies are actively focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position and meet the growing demand for early and accurate diagnostic solutions. Leading players such as Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter), and F. Hoffmann-La Roche Ltd. dominate the landscape with extensive ELISA test portfolios, robust R&D investments, and global distribution networks. These companies are advancing automated, high-sensitivity ELISA systems to enhance usability and accuracy in both clinical and research applications.
In addition, mid-sized and emerging companies—including Bio-Techne, RayBiotech, OriGene Technologies, and Elabscience—are gaining momentum by focusing on niche disease areas and custom assay development. Firms like GenScript Biotech and Eurofins Scientific are also expanding their presence, particularly in Asia-Pacific and European markets, through local manufacturing and strategic collaborations. Technological advancements are playing a key role in shaping the market. Innovations such as multiplex ELISA, portable diagnostic platforms, and fully automated systems are driving competition by improving efficiency, affordability, speed, and diagnostic accuracy.
Recent Developments:
- May 2024: Merck KGaA announced the acquisition of Mirus Bio for approximately USD 600 million. Although the focus was on viral vector manufacturing, the acquisition enhances Merck’s downstream analytics capabilities, including ELISA-based platforms—supporting its strategic vision to strengthen its life sciences portfolio, particularly in gene therapy and bioprocessing diagnostics.
- April 2023: Thermo Fisher Scientific Inc. launched a next-generation ELISA kit platform featuring advanced signal detection technology. The new kits offer greater sensitivity, faster results, and improved assay consistency, reinforcing Thermo Fisher’s commitment to innovation in both clinical diagnostics and research applications.
- February 2023: Abcam plc expanded its ELISA offerings with the launch of recombinant monoclonal antibody-based ELISA kits for cancer and autoimmune disease research. These kits provide enhanced specificity and reproducibility, meeting the needs of researchers in academic and biopharmaceutical settings.
- February 2023: Merck KGaA, through its life science division MilliporeSigma, introduced multiplex ELISA kits for the simultaneous detection of cytokines and chemokines in preclinical research. These kits improve assay efficiency and data depth, supporting Merck’s expansion in the biomarker discovery and translational research space.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ELISA DIAGNOSTICS TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- Abcam Limited
- BD
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- BioVision, Inc.
- Creative Diagnostics
- Danaher Corporation
- Elabscience Biotechnology Inc.
- Enzo Biochem, Inc.
- Eurofins Scientific SE
- F. Hoffmann-La Roche Ltd
- GenScript Biotech Corporation
- Merck KGaA
- MyBioSource, Inc.
- OriGene Technologies, Inc.
- PerkinElme.
- RayBiotech, Inc.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Others
GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Competitive ELISA
- Indirect ELISA
- Multiple & Portable ELISA
- Sandwich ELISA
GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Immunology
- Inflammation
- Infectious diseases
- Cancer
- Protein quantification
- Other Applications
GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Veterinary Hospitals & Diagnostic Laboratories
GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. ELISA Diagnostics Tests Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. ELISA Diagnostics Tests Market Snippet by Test Type
2.1.2. ELISA Diagnostics Tests Market Snippet by Application
2.1.3. ELISA Diagnostics Tests Market Snippet by End User
2.1.4. ELISA Diagnostics Tests Market Snippet by Country
2.1.5. ELISA Diagnostics Tests Market Snippet by Region
2.2. Competitive Insights
3. ELISA Diagnostics Tests Key Market Trends
3.1. ELISA Diagnostics Tests Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. ELISA Diagnostics Tests Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. ELISA Diagnostics Tests Market Opportunities
3.4. ELISA Diagnostics Tests Market Future Trends
4. ELISA Diagnostics Tests Industry Study
4.1. PESTEL Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. ELISA Diagnostics Tests Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. ELISA Diagnostics Tests Market Landscape
6.1. ELISA Diagnostics Tests Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. ELISA Diagnostics Tests Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
7.1.2. Competitive ELISA
7.1.3. Indirect ELISA
7.1.4. Multiple & Portable ELISA
7.1.5. Sandwich ELISA
8. ELISA Diagnostics Tests Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Immunology
8.1.3. Inflammation
8.1.4. Infectious diseases
8.1.5. Cancer
8.1.6. Protein quantification
8.1.7. Other Applications
9. ELISA Diagnostics Tests Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals & Diagnostic Centers
9.1.3. Pharmaceutical & Biotechnology Companies
9.1.4. Veterinary Hospitals & Diagnostic Laboratories
10. ELISA Diagnostics Tests Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. ELISA Diagnostics Tests Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. ELISA Diagnostics Tests Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. ELISA Diagnostics Tests Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. ELISA Diagnostics Tests Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. ELISA Diagnostics Tests Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- ELISA Diagnostics Tests Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Abbott
11.2.2. Abcam Limited
11.2.3. BD
11.2.4. Bio-Rad Laboratories, Inc.
11.2.5. Bio-Techne Corporation
11.2.6. BioVision, Inc.
11.2.7. Creative Diagnostics
11.2.8. Danaher Corporation
11.2.9. Elabscience Biotechnology Inc.
11.2.10. Enzo Biochem, Inc.
11.2.11. Eurofins Scientific SE
11.2.12. F. Hoffmann-La Roche Ltd
11.2.13. GenScript Biotech Corporation
11.2.14. Merck KGaA
11.2.15. MyBioSource, Inc.
11.2.16. OriGene Technologies, Inc.
11.2.17. PerkinElme.
11.2.18. RayBiotech, Inc.
11.2.19. Siemens Healthineers AG
11.2.20. Thermo Fisher Scientific Inc.
11.2.21. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
